Dr. Grossman is CEO of NYU Langone Health and Dean of NYU School of Medicine, which was renamed in his honor in 2019. In this role, he oversees more than 45,000 employees, students, and faculty across 6 inpatient locations and over 320 sites throughout the New York region and in Florida. Dr. Grossman increased NYU Langone’s revenue from $2 billion in 2007 to $10.2 billion in 2021, and more than $3.9 billion in philanthropy has also been raised. Also of note, NYU Langone’s National Institutes of Health (NIH) 2021 research awards totaled $815 million—an increase of more than 532 percent compared to 2007.
As dean of NYU Grossman School of Medicine, Dr. Grossman led the historic and unprecedented initiative of providing tuition free medical education for all students in its MD degree program. He also curated a new curriculum for the 21st Century, which emphasizes clinical training from the beginning of medical school and includes a revolutionary 3 year MD program for select candidates.
Dr. Grossman has been named to Time magazine’s list of the 50 most influential healthcare leaders who changed the state of healthcare in America. Additionally, he was named a “Living Landmark” by the New York Landmarks Conservancy. A prolific and highly respected scientist, Dr. Grossman was awarded the Javits Neuroscience Investigator Award by the NIH in 1999. He was a member and chairman of the Diagnostic Radiology Study Section at the NIH, was appointed to the NIH’s National Advisory Council and became the first recipient of the Outstanding Contributions in Research Award.